Fig. 3From: Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinomaPotential therapeutic targets and agents to reverse ESCC radioresistance. (A) Potential therapeutic agents targeting key pathways. (B) Potential agents for epigenetic therapy. DNMT: DNA methyltransferase; KDM: Histone lysine demethylase; HDAC: Histone deacetylase; VPA: Valproic acidBack to article page